TOCQUEVILLE ASSET MANAGEMENT L.P. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$2,000
-60.0%
10,0000.0%0.00%
Q3 2018$5,0000.0%10,0000.0%0.00%
Q2 2018$5,000
-78.3%
10,0000.0%0.00%
Q1 2018$23,000
-17.9%
10,0000.0%0.00%
Q4 2017$28,000
-3.4%
10,0000.0%0.00%
Q3 2017$29,000
+16.0%
10,0000.0%0.00%
Q2 2017$25,000
-30.6%
10,0000.0%0.00%
Q1 2017$36,000
+2.9%
10,0000.0%0.00%
Q4 2016$35,000
-12.5%
10,0000.0%0.00%
Q3 2016$40,000
-54.5%
10,000
-50.0%
0.00%
-100.0%
Q2 2016$88,000
+131.6%
20,000
+100.0%
0.00%0.0%
Q1 2016$38,000
-96.7%
10,000
-86.4%
0.00%
-93.8%
Q4 2015$1,151,000
+130.2%
73,400
+54.9%
0.02%
+128.6%
Q3 2015$500,000
-59.1%
47,400
-2.3%
0.01%
-50.0%
Q2 2015$1,223,000
-7.6%
48,500
+2.1%
0.01%
-12.5%
Q1 2015$1,324,000
+93.6%
47,500
+26.7%
0.02%
+128.6%
Q4 2014$684,000
+83.4%
37,500
+30.2%
0.01%
+75.0%
Q3 2014$373,000
-32.1%
28,800
-14.4%
0.00%
-20.0%
Q2 2014$549,000
-37.7%
33,650
-32.5%
0.01%
-58.3%
Q1 2014$881,000
-22.3%
49,850
+6.4%
0.01%
-20.0%
Q4 2013$1,134,000
+26.0%
46,850
+84.4%
0.02%
+36.4%
Q3 2013$900,000
+179.5%
25,400
+23.3%
0.01%
+175.0%
Q2 2013$322,00020,6000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders